GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,471
Funds Holding Change
+10
Funds Holding Growth
+0.3%
Value
$641B
Holding in Top 10
415
Top 10 Change
-46
Top 10 Growth
-10%
Value Growth
-0.2%
New
158
Increased
1,629
Reduced
1,445
Closed
109
Capital Inflow
$15.5B
Capital Outflow
$26B
Net Capital Flow
-$10.5B
Capital Flow Change
-$22.4B
Calls
$6.55B
Puts
$6.31B
Net Calls
+$242M
Put/Call Ratio
0.96